News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research
Photo taken from: Henry Rodriguez / LinkedIn
Jul 12, 2023, 03:28

ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research

Exciting news! ETH Zürich (Switzerland) and the United States National Cancer Institute (NCI) have just signed an extension of their MOU for Proteogenomics Cancer Research. Proud to have the Switzerland International Cancer Proteogenome Consortium (ICPC) team at ETH Zürich, contributing to our cancer moonshot global fight against cancer. Together, we’re pushing the boundaries of science to fight against this relentless disease. https://lnkd.in/ex4vhTFP

 

Source:

NCI OncoDaily Oncology proteogenomics Research switzerland
Special Coverage
Blog
Nov 18, 2024, 17:16
Wafik S. El-Deiry: Peer-to-peer call challenge delay Folfiri Plus Cetuximab treatment for mCRC
Blog
Nov 18, 2024, 17:13
Vincent Rajkumar: Working on refining response criteria in myeloma
Blog
Nov 18, 2024, 16:59
Refining the First Strike Against EGFR-Mutated Advanced NSCLC - PeerView Institute for Medical Education
Blog
Nov 18, 2024, 16:55
Ruth Fein: Together we can change the conversation around chronic cancers
Blog
Nov 18, 2024, 16:50
Cervical Cancer Elimination Day of Action 2024 - Medicaid Cancer Foundation
Blog
Nov 18, 2024, 16:50
Michael Duruisseaux: Prognostic value of neutrophil to lymphocyte ratio before adjuvant durvalumab in locally advanced NSCLC
Blog
Nov 18, 2024, 16:39
Cristiane Bergerot: Psycology Society suffering in patients with cancer remains a worldwide unmet need
Insight
Nov 18, 2024, 16:36
Very last chance to apply for the CancerX Accelerator Startup
Insight
Nov 18, 2024, 16:31
Andreas Koulouris: Incredible opportunity to participate in the Lung Cancer Preceptorship in Paris
Insight
Nov 18, 2024, 16:04
Manlio Vinciguerra: Circulating histone signature of Diffuse Intrinsic Pontine Glioma
Insight
Nov 18, 2024, 15:58
Petros Grivas: Fantastic experience to present at WA medical oncology society
Opinion
Nov 18, 2024, 15:57
Marking 4 years of WHO's Cervical Cancer Elimination movement - IARC